QCM

ß-Galactocerebrosidase (Galc) Newborn Screening Test System

Product code
QCM
Device name
ß-Galactocerebrosidase (Galc) Newborn Screening Test System
Device class
Class 2
21 CFR
21 CFR 862.1488
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
Flag
Third-party review eligible

FDA classification definition

For quantitative measurement of the activity of ß-galactocerebrosidase (GALC) from newborn dried blood spot specimens as an aid in screening newborns for Krabbe disease.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QCM
Classification and pathway per current FDA publications. Data from openFDA (CC0).